CING RSI Chart
Last 7 days
5.3%
Last 30 days
-5.9%
Last 90 days
-31.0%
Trailing 12 Months
-95.9%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 11, 2024 | werth peter j. | acquired | 753 | 0.000727054 | 1,036,010 | - |
Sep 15, 2023 | callahan jennifer l. | bought | 3,348 | 0.6697 | 5,000 | corporate controller |
Aug 11, 2023 | werth peter j. | bought | 1,000,000 | 0.5485 | 1,823,160 | - |
May 15, 2023 | callahan jennifer l. | bought | 2,020 | 1.01 | 2,000 | corporate controller |
May 12, 2023 | callahan jennifer l. | bought | 4,320 | 1.08 | 4,000 | corporate controller |
Dec 16, 2022 | schaffer shane j. | bought | 10,166 | 1.0166 | 10,000 | chief executive officer |
Dec 14, 2022 | callahan jennifer l. | bought | 7,467 | 0.9894 | 7,548 | corporate controller |
Dec 14, 2022 | schaffer shane j. | bought | 13,399 | 1.01 | 13,267 | chief executive officer |
Dec 13, 2022 | werth peter j. | bought | 28,421 | 0.9823 | 28,934 | - |
Dec 13, 2022 | schaffer shane j. | bought | 1,750 | 1.01 | 1,733 | chief executive officer |
Which funds bought or sold CING recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | BANK OF AMERICA CORP /DE/ | unchanged | - | -3.00 | 3.00 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -6.23 | -17,314 | 2,698 | -% |
May 15, 2024 | Altium Capital Management LP | unchanged | - | -2,403 | 5,697 | -% |
May 15, 2024 | ARMISTICE CAPITAL, LLC | reduced | -95.00 | -182 | 433 | -% |
May 15, 2024 | SABBY MANAGEMENT, LLC | reduced | -16.18 | -9,698,000 | 7,078,000 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 896 | 2,688 | 8,892 | -% |
May 15, 2024 | Hudson Bay Capital Management LP | unchanged | - | -1,792 | 4,532 | -% |
May 14, 2024 | Qube Research & Technologies Ltd | new | - | 110 | 110 | -% |
May 13, 2024 | HRT FINANCIAL LP | new | - | 11,000 | 11,000 | -% |
May 13, 2024 | UBS Group AG | reduced | -99.82 | -1,424 | 1.00 | -% |
Unveiling Cingulate Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Cingulate Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Cingulate Inc. News
Balance Sheet | ||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2020Q4 |
Assets | 57.4% | 5,495 | 3,491 | 5,870 | 5,227 | 7,163 | 11,405 | 15,377 | 13,804 | 18,433 | 22,886 | 5,788 |
Current Assets | 371.3% | 2,727 | 579 | 2,902 | 2,038 | 3,753 | 7,870 | 11,834 | 10,102 | 14,574 | 18,882 | 1,790 |
Cash Equivalents | 2025.0% | 1,114 | 52.00 | 1,986 | 350 | 1,739 | 5,356 | 9,796 | 8,196 | 12,614 | 16,493 | 1,198 |
Net PPE | -3.2% | 2,464 | 2,546 | 2,531 | 2,686 | 2,841 | 2,905 | 2,851 | 2,953 | 3,054 | 3,145 | 3,039 |
Liabilities | -78.0% | 2,278 | 10,361 | 5,967 | 11,326 | 7,081 | 7,523 | 7,010 | 1,619 | 2,414 | 2,043 | 4,495 |
Current Liabilities | -78.0% | 2,245 | 10,226 | 5,732 | 10,995 | 6,659 | 7,013 | 6,406 | 924 | 1,631 | 1,177 | 3,361 |
Shareholder's Equity | 146.8% | 3,216 | -6,869 | - | - | 82.00 | 3,882 | 8,367 | 12,185 | 16,019 | 20,844 | 1,292 |
Retained Earnings | -3.2% | -95,915 | -92,943 | -86,008 | -80,029 | -73,413 | -69,408 | -64,803 | -60,776 | -56,735 | -51,732 | -31,022 |
Additional Paid-In Capital | 15.2% | 99,132 | 86,074 | 85,912 | 73,930 | 73,494 | 73,290 | 73,169 | 72,963 | 72,756 | 72,576 | - |
Shares Outstanding | 329.2% | 5,010 | 1,168 | - | 12,057 | 11,309 | - | - | 11,309 | 11,309 | - | - |
Float | - | - | - | - | 7,800 | - | - | - | 11,500 | - | - | - |
Cashflow (Quarterly) | |||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Cashflow From Operations | -241.3% | -8,746 | -2,562 | -4,291 | -4,603 | -3,576 | -4,206 | -3,399 | -4,412 | -3,864 | -4,622 | -2,585 | -1,550 | -1,674 | - |
Share Based Compensation | 6.5% | 165 | 155 | 236 | 217 | 204 | 206 | 206 | 207 | 182 | - | - | - | - | - |
Cashflow From Investing | 56.4% | -81.51 | -186 | - | -1* | -37.13 | -143 | 3.00 | -2.48 | -10.40 | -710 | -15.77 | -22.49 | -66.47 | - |
Cashflow From Financing | 1112.8% | 9,889 | 815 | 5,928 | 3,215 | -3.92 | -89.78 | 4,996 | -3.74 | -3.68 | 19,910 | 3,472 | 1,809 | 1,351 | - |
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 1,806,985 | $ 2,128,616 |
General and administrative | 1,141,232 | 1,721,379 |
Operating loss | (2,948,217) | (3,849,995) |
Interest and other income (expense), net | (24,260) | (154,892) |
Loss before income taxes | (2,972,477) | (4,004,887) |
Income tax benefit (expense) | ||
Net loss and comprehensive loss | $ (2,972,477) | $ (4,004,887) |
Net loss per share of common stock, basic | $ (0.60) | $ (7.08) |
Net loss per share of common stock, diluted | $ (0.60) | $ (7.08) |
Weighted average number of shares used in computing net loss per share of common stock, basic | 4,945,507 | 565,471 |
Weighted average number of shares used in computing net loss per share of common stock, diluted | 4,945,507 | 565,471 |
Consolidated Balance Sheets (Unaudited) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,113,830 | $ 52,416 |
Miscellaneous receivables | 2,247 | 14,622 |
Prepaid expenses and other current assets | 1,610,765 | 511,556 |
Total current assets | 2,726,842 | 578,594 |
Property and equipment, net | 2,463,874 | 2,545,965 |
Operating lease right-of-use assets | 303,799 | 366,877 |
Total assets | 5,494,515 | 3,491,436 |
Current liabilities: | ||
Accounts payable | 737,949 | 5,199,105 |
Accrued expenses | 1,117,638 | 1,651,519 |
Note payable | 3,000,000 | |
Finance lease liability, current | 17,326 | 17,057 |
Operating lease liability, current | 372,338 | 358,085 |
Total current liabilities | 2,245,251 | 10,225,766 |
Long-term liabilities: | ||
Finance lease liability, net of current | 4,436 | |
Operating lease liability, net of current | 33,145 | 130,663 |
Total long-term liabilities | 33,145 | 135,099 |
Total liabilities | 2,278,396 | 10,360,865 |
Stockholders’ Equity | ||
Common Stock, $0.0001 par value; 240,000,000 shares authorized and 5,010,470 and 1,167,521 shares issued and outstanding as of March 31, 2024 and December 31, 2023 | 502 | 118 |
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of March 31, 2024 and December 31, 20223 | ||
Additional Paid-in-Capital | 99,131,537 | 86,073,896 |
Accumulated deficit | (95,915,920) | (92,943,443) |
Total stockholders’ equity | 3,216,119 | (6,869,429) |
Total liabilities and stockholders’ equity | $ 5,494,515 | $ 3,491,436 |